Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
about
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel.Long-term safety of growth hormone-A combined registry analysis.Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study.
P2860
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@ast
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@en
type
label
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@ast
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@en
prefLabel
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@ast
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@en
P2093
P2860
P50
P356
P1433
P1476
Description of the SAGhE Cohor ...... th Recombinant Growth Hormone.
@en
P2093
Anita C S Hokken-Koelega
Birgit Borgström
Claudio Giacomozzi
Emmanuel Ecosse
Fabienne Landier
Gary Butler
Gladys R J Zandwijken
Grit Sommer
Jean-Claude Carel
Joël Coste
P2860
P304
P356
10.1159/000435856
P50
P577
2015-07-23T00:00:00Z